PortfoliosLab logo

ALPS Medical Breakthroughs ETF

SBIO
ETF · Currency in USD
ISIN
US00162Q5936
CUSIP
00162Q593
Issuer
SS&C
Inception Date
Dec 31, 2014
Region
North America (U.S.)
Category
Health & Biotech Equities
Expense Ratio
0.50%
Index Tracked
S-Network Medical Breakthroughs Index
ETF Home Page
www.etf.com
Asset Class
Equity

Asset Class Size

Small-Cap

Asset Class Style

Growth

SBIOPrice Chart


Chart placeholderClick Calculate to get results

SBIOPerformance

The chart shows the growth of $10,000 invested in ALPS Medical Breakthroughs ETF on Jan 2, 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $19,402 for a total return of roughly 94.02%. All prices are adjusted for splits and dividends.


SBIO (ALPS Medical Breakthroughs ETF)
Benchmark (S&P 500)

SBIOReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-2.10%
6M-6.31%
YTD-10.13%
1Y7.39%
5Y15.31%
10Y10.23%

SBIOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

SBIOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ALPS Medical Breakthroughs ETF Sharpe ratio is 0.14. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


SBIO (ALPS Medical Breakthroughs ETF)
Benchmark (S&P 500)

SBIODividends

ALPS Medical Breakthroughs ETF granted a 0.00% dividend yield in the last twelve months, as of Oct 23, 2021. The annual payout for that period amounted to $0.00 per share.


PeriodTTM2020201920182017201620152014
Dividend$0.00$0.00$0.02$0.78$0.58$0.00$0.00$0.00

Dividend yield

0.00%0.00%0.04%2.79%1.77%0.00%0.00%0.00%

SBIODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


SBIO (ALPS Medical Breakthroughs ETF)
Benchmark (S&P 500)

SBIOWorst Drawdowns

The table below shows the maximum drawdowns of the ALPS Medical Breakthroughs ETF. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ALPS Medical Breakthroughs ETF is 49.69%, recorded on Nov 3, 2016. It took 398 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-49.69%Jul 20, 2015329Nov 3, 2016398Jun 6, 2018727
-39.3%Dec 26, 201955Mar 16, 202069Jun 23, 2020124
-34.69%Feb 9, 2021134Aug 19, 2021
-32.5%Oct 1, 201859Dec 24, 2018232Nov 25, 2019291
-13.78%Apr 24, 20155Apr 30, 201514May 20, 201519
-13.03%Jun 24, 202056Sep 11, 202018Oct 7, 202074
-11.31%Mar 20, 20154Mar 25, 201512Apr 13, 201516
-6.72%Jun 7, 201871Sep 17, 20189Sep 28, 201880
-6.3%Jan 28, 20156Feb 4, 20158Feb 17, 201514
-6.29%Jun 23, 20155Jun 29, 20159Jul 13, 201514

SBIOVolatility Chart

Current ALPS Medical Breakthroughs ETF volatility is 16.70%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


SBIO (ALPS Medical Breakthroughs ETF)
Benchmark (S&P 500)

Portfolios with ALPS Medical Breakthroughs ETF


Loading data...

More Tools for ALPS Medical Breakthroughs ETF